Detection of anti-IgA antibodies using the particle gel immunoassay: A rapid test for increased patient safety

Blood Transfusion

Volumn 12, Issue 3, 2014, Pages 334-339

  Oltean, Simona ^a   Epure, Andreea ^a   Lindström, Karin ^a   Pardi, Cecilia ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaphylactic transfusion reaction; Anti IgA antibodies; IgA deficiency; Particle gel immunoassay; Transfusion urgency

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; ALLOANTIBODY; IMMUNOGLOBULIN A;

ANAPHYLAXIS; ANTIBODY DETECTION; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; PATIENT SAFETY; RAPID TEST; REPRODUCIBILITY; SCREENING; SENSITIVITY AND SPECIFICITY; ADVERSE EFFECTS; BLOOD; FEMALE; MALE;

ANAPHYLAXIS; BLOOD TRANSFUSION; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN A; ISOANTIBODIES; MALE; PATIENT SAFETY;

EID: 84904640574     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2014.0219-13     Document Type: Article

References (17)

1. Sandler SG, Eckrich R, Malamut D, et al. Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions. Blood 1994; 84: 2031-35. (Pubitemid 24286156)
2. Sandler SG, Zantek ND. Review: IgA anaphylactic transfusion reactions. Part II. Clinical diagnosis and bedside management. Immunohematology 2004; 20: 234-8. (Pubitemid 39612586)
3. Vassallo RR. Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence and supply of IgA-deficient products. Immunohematology 2004; 20: 226-33.
4. Yuan S, Goldfinger D. A readily available assay for anti-immunoglobulin A: is this what we have been waiting for? Transfusion 2008; 48: 2048-50.
5. Hammarström L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120: 225-31. (Pubitemid 30304214)
6. Litzman J, Sevcikova I, Stikarovska D, et al. IgA deficiency in Czech healthy individuals and selected patient groups. Int Arch Allergy Immunol 2000; 123: 177-80.
7. Koskinen S, Tölö H, Hirvonen M, et al. Longterm follow-up of anti-IgA antibodies in healthy IgA-deficient adults. J Clin Immunol 1995; 15: 194-8.
8. Munks R, Booth JR, Sokol RJ. A comprehensive IgA service provided by a blood transfusion center. Immunohematology 1998; 14: 155-60. (Pubitemid 28550905)
9. Eckrich RJ, Mallory D, Sandler SG. Laboratory tests to exclude IgA deficiency in the investigation of suspected anti-IgA transfusion reactions. Transfusion 1993; 33: 488-92. (Pubitemid 23183209)
10. Petty RE, Palmer NR, Cassidy JT, et al. The association of autoimmune diseases and anti-IgA antibodies in patients with selective IgA deficiency. Clin Exp Immunol 1979; 37: 83-8. (Pubitemid 9201949)
11. Bjorkander J, Hammarstrom L, Smith CI, et al. Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies. J Clin Immunol 1987; 7: 8-15. (Pubitemid 17028769)
12. Sandler SG. How I manage patients suspected of having had an IgA anaphylactic transfusion reaction. Transfusion 2006; 46: 10-3. (Pubitemid 43381779)
13. Salama A, Schwind P, Schönhage K, et al. Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay. Vox Sang 2001; 81: 45-8. (Pubitemid 35334303)
14. Brown R, Nelson M, Aklilu E, et al. An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti-IgA) and IgA deficiency. Transfusion 2008; 48: 2057-9.
15. Palmer DS, O'Toole J, Montreuil T, et al. Evaluation of particle gel immunoassays for the detection of severe immunoglobulin A deficiency and anti-human immunoglobulin A antibodies. Transfusion 2012; 52: 1792-8.
16. Feng ML, Zhao YL, Shen T, et al. Prevalence of immunoglobulin A deficiency in Chinese blood donors and evaluation of anaphylactic transfusion reaction risk. Transfus Med 2011; 21: 338-43.
17. Ahrens N, Höflich C, Bombard S, et al. Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment. Clin Exp Immunol 2008; 51: 55-8.